Benfield competitors

Karim Ghoneim is a Chief Executive Officer at KMG CHEMICALS INC and is based in United States.

Joe joined Matthews International Corporation in 1997 as general counsel. Two years later, he became President of Caggiati, the Company's wholly owned bronze subsidiary in Parma, Italy. While in Europe, he acquired and managed nine businesses to create the largest packaging graphics group in Europe. Joe returned from Europe in 2004 to assume the role of president of the Company's casket operations. In 2005, he was appointed to the position of President and Chief Operating Officer of Matthews, and was also elected to the Board of Directors. One year later, Joe was named President and Chief Executive Officer. Prior to joining Matthews International, Joe was Vice President and General Counsel for Thrift Drug, Inc. He was also an associate attorney at Reed Smith Shaw & McClay, focusing on the corporate and taxation area with experience in litigation, real estate and estate planning. Joe began his career at Touche Ross & Co. as a senior auditor where he gained practical business, tax and auditing experience in manufacturing, banking, retail and advertising. Joe serves as the chairman of the finance committee at St. Vincent College and is a member of the Federated Investors, Inc. Board of Directors. Joe earned his BA in accounting at St. Vincent College and received a Juris Doctorate degree from the University of Pittsburgh School of Law.

Ron has been a member of the Century Group management team since 1995 and was appointed CEO in 2007. Over his tenure he has held various responsibilities including President and COO prior to his appointment to CEO. Ron began his career with the firm as an Associate with responsibility for direct recruiting and sourcing of candidates for the firm’s clients. Since 1992, Ron has managed numerous clients and has successfully executed hundreds of searches in a variety of industries including biotech, consumer products, software, financial services, investments and entertainment. Ron holds a Bachelor Degree from Whittier College and was previously with a national firm prior to joining Century Group in 1990. He currently oversees all corporate administration, business development research, recruiting, and marketing for retained search, contingency search and project consulting practices. Ron has been published and quoted on the field of executive search by a variety of publications including the Wall Street Journal, Fordyce Letter, and Los Angeles Business Journal. He served on numerous committees and boards and is a judge for the annual CFO of the year Awards for The Los Angeles Business Journal.

Transformational and innovative life sciences CEO with a proven track record of growing and turning around businesses with significant value creation. Domain expertise in medical devices, mobile and digital health and pet health. Full-function general management experience in both start-up and established organizations with responsibility from 3 to 500 people. Expert in developing and launching new and complex technologies, building, developing as well as restructuring teams and managing intercultural businesses, including four expatriate assignments on two continents. Fluent in French, German and Italian. OBJECTIVE - CEO of a pre-revenue, growth stage, turnaround, pre-IPO or public company - Operating/consulting partner with VC, PE or Consulting Firm SELECT ACCOMPLISHMENTS • Successfully ran two public companies, Vasomedical, Inc. (NASDAQ) and BioSig Technologies (OTCQB at the time now on NASDAQ) and took BioSig public through a self-filed S1 followed by raising $15 million in private placements. • Conducted two successful turnarounds, Vasomedical and HeartSine Technologies, both nearly out of cash when I joined them. • Introduced several new, complex products at Medtronic, SCIMED, Boston Scientific, US Surgical, Sorin, and HeartSine. • Built or transformed distribution networks at Boston Scientific, US Surgical, Datascope, Sorin and HeartSine Technologies. • Grew business from $94 to $150 million in a year at Boston Scientific and from $29 to $40 million at Sorin (also in 1 year). KEY SKILLS Executive Leadership - Fund Raising - Investor Relations - Strategic Planning & Implementation - General Management - P&L Management - Product Development - Clinical Development - Quality & Regulatory Management - Innovation - Entrepreneurship - Intrepreneurship - Cross Functional Team Leadership - Strategic Partnerships - Mergers and Acquisitions - Team Building - Coaching - Mentoring - Transformational Leadership - Change Management - Product Management - Strategic Marketing - Brand Management - Commercial Strategy - Global Business Development - Market Development - Channel Development - Customer Relationship Building - Medical Devices - Capital Equipment - Digital Health - Mobile Health - Program Management Telephone: 617-286-4997 E-mail: gregorydcash@gmail.com